Skip to main content

Table 1 Demographic and Anthropometric Characteristics of the Sample

From: Correlates of weight gain during long-term risperidone treatment in children and adolescents

Characteristic

Age, years

11.8 (±2.9)

Males, n (%)

98 (89%)

Tanner Stage: I, II, III, IV, V (%)

36/14/18/22/10

Race, n (%)

 

  White

87 (79)

  African American

17 (15)

  Hispanic

5 (5)

  Other

1 (1)

Anthropometric/Metabolic Data

Birth Weight z Scorea (n=98)

-0.29 (±0.99)

Baseline Weight z Scoreb

0.17 (±1.02)

Baseline BMI z Scoreb (n=107)

0.18 (±1.05)

Enrollment Weight, Kg

49.1 (±18.3)

Enrollment Weight z Score

0.72 (±1.03)

Enrollment Weight, Kg/m2

20.9 (±4.6)

Enrollment BMI z Score

0.73 (±1.02)

  1. a This was adjusted for sex and gestational age [31].
  2. b Baseline sex- and age-adjusted weight or body mass index (BMI) z scores included those available upon or within the month prior to starting risperidone.
Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000